Driving commercial impact for a global leader in genomic datasets
While some consider this firm to be the world’s largest and best provider of genomic research data for life sciences, the firm needed to evolve their pricing and portfolio to remove persistent adoption barriers and achieve value-based revenues. We engaged the ecosystem, uncovered primary adoption barriers related to mismatched offerings, validated and launched a new […]
Driving adoption of consumer genomics for a market-leader
Illumina needed to accelerate adoption of their Understand Your Genome program to grow the genomics market. At the center of this was their MyGenome experience, and they wanted to understand and remove the user and adoption barriers in this offering. We prototype-validated the new solution with dozens of users and created a detailed update to […]
Commercial acceleration of a portfolio of oncology test solutions
This market-leading provider of both predictive and diagnostic testing needed to uncover accelerating levers in existing channels, as well as unlock new markets. We tested and validated prototype experiences across the entire customer journey, implemented impactful commercial solutions from awareness to ordering to sample return to return-of-results to referral & cross-sell. We then put in […]
Driving standard of care for a market-leading prostate cancer test
Myriad’s Prolaris team, focused on sales of prostate cancer molecular testing, was concerned about leveling sales and having limited success in achieving standard of care. We identified the barriers and market-validated the methods and assets needed to overcome those barriers. The results were accelerated sales per urologist, as well as an increase in total urologists […]
Creating a new RWD/RWE product portfolio to drive sales in life sciences
Our client needed help to define, validate, and launch its first portfolio of RWD and RWE life sciences offerings, including clinical trial design, outcomes research portfolio planning, FDA submission, reimbursement approval acceleration, and commercial sales acceleration. The portfolio was designed, market-validated and launched. Time-to-close sales contracts was reduced 40%. Sales increased by multiples at customers […]
Business strategy and fundraising for a global NGS company
We collaborated with executive management to shape and deliver the combined corporate and fundraising strategy, founded in a positioning as a global platform both enabling and delivering solutions across all of genomics and the globe. Results included a raise of $240M and a growing portfolio of seven businesses.